National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting, 9055-9056 [2013-02792]

Download as PDF 9055 Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices stakeholder meeting, progress toward better respirators for healthcare workers will be discussed. FOR FURTHER INFORMATION CONTACT: Dr. Ronald E. Shaffer, Senior Scientist, NIOSH NPPTL Office of the Director at NPPTLEventsHealthcar@cdc.gov, telephone (412) 386–6111, fax (412) 386–6617. other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: January 29, 2013. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. BILLING CODE 4163–18–P Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–02791 Filed 2–6–13; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, Announces the Following Meeting ICD–9–CM Coordination and Maintenance Committee (C&M) meeting. NAME: DEPARTMENT OF HEALTH AND HUMAN SERVICES TIME AND DATE: BILLING CODE 4163–19–P Centers for Disease Control and Prevention PLACE: DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review [FR Doc. 2013–02742 Filed 2–6–13; 8:45 am] Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial review mstockstill on DSK4VPTVN1PROD with NOTICES The meeting announced below concerns Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region, Funding Opportunity Announcement (FOA) IP13–002; and Strengthening Global Animal-Human Interface Activities for Avian Influenza and other Zoonotic Diseases, FOA CK13–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–3:00 p.m., March 28, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region, FOA IP13–002; and Strengthening Global Animal-Human Interface Activities for Avian Influenza and other Zoonotic Diseases, FOA CK13–002’’. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and VerDate Mar<15>2010 17:45 Feb 06, 2013 Jkt 229001 The meeting announced below concerns Building Healthcare Practitioner Capacity Around HPV Vaccine Communication, Funding Opportunity Announcement (FOA) IP13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–5:00 p.m., April 10, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Building Healthcare Practitioner Capacity around HPV Vaccine Communication, FOA IP13–001’’. Contact Person For More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718–8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. 9:00 a.m.–5:00 p.m., March 5, 2013. Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. The meeting will be broadcast live via Webcast at http://www.cms.gov/ live/ STATUS: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend a specific ICD–9–CM C&M meeting on March 5, 2013, must submit their name and organization by February 22, 2013, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Please register to attend the meeting on-line at: http://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786–4510 or Marilu.hue@cms.hhs.gov), for questions about the registration process. SECURITY CONSIDERATIONS: Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. The ICD–9–CM Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Ninth Revision, Clinical Modification, the International Classification of Diseases, Tenth Revision, Clinical Modification and ICD–10—Procedure Coding System [FR Doc. 2013–02790 Filed 2–6–13; 8:45 am] MATTERS TO BE DISCUSSED: BILLING CODE 4163–18–P include: PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 PURPOSE: E:\FR\FM\07FEN1.SGM 07FEN1 Agenda items 9056 Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices March 5, 2013 DEPARTMENT OF HEALTH AND HUMAN SERVICES ICD–9–CM Topics Centers for Medicare & Medicaid Services Infusion of Prothrombin Complex Concentrate Transprostatic Guided Implantable Struts [Document Identifier: CMS–10464] Agency Information Collection Activities: Proposed Collection; Comment Request ICD–10 Topics ICD–10 Implementation Announcements ICD–10 Update on National Coverage Determinations ICD–10 Impact Analysis Transprostatic Guided Implantable Struts ICD–10 HAC Translations ICD–10–PCS Addendum ICD–10–CM Diagnosis Topics Complications of urinary devices (representation) Gluten sensitivity Salter Harris fractures ICD–10–CM Addendum Agenda items are subject to change as priorities dictate. Note: CMS and NCHS will no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS Web sites prior to the meeting at http://www.cms.hhs.gov/ICD9Provider DiagnosticCodes/03_meetings. asp#TopOfPage and http://www.cdc.gov/ nchs/icd/icd9cm_maintenance.htm. mstockstill on DSK4VPTVN1PROD with NOTICES CONTACT PERSONS FOR ADDITIONAL INFORMATION: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, email dfp4@cdc.gov, telephone 301–458–4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland, 21244, email marilu.hue@cms.hhs.gov, telephone 410–786–4510 (procedures). The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–02792 Filed 2–6–13; 8:45 am] BILLING CODE 4160–18–P VerDate Mar<15>2010 17:45 Feb 06, 2013 Jkt 229001 Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: New Collection; Title of Information Collection: Agent/broker data collection in Federally Facilitated Health Insurance Exchanges; Use: CMS will collect data, including licensure and personally identifiable information, from agent/brokers to register them with the federally-facilitated exchange (FFE) through the Exchange Portal. A key component of the registration process requiring data collection is verifying the agent/broker’s licensure status, as well as any issuer appointments. Agents/ brokers will enter basic identifying information on the Exchange Portal during the initial registration phase. Once registration is successfully completed, agent/brokers will be routed to CMS’ LMS to access and complete required training and exams. The user names and zip codes that agent/brokers provided during training will be used to record their training history through CMS LMS, and communicate training results with the Exchange Portal. As accompanying modules demonstrate, the training and exams will ensure agent/brokers possess the basic knowledge required to enroll individuals and small business health options plan (SHOP) employers/ employees through the Exchange. AGENCY: PO 00000 Frm 00030 Fmt 4703 Sfmt 9990 Additionally, CMS will use the collected data for oversight and monitoring of agent/brokers, and to ensure compliance with the ACA provisions under 45 CFR 155.220. If CMS detects anomalies, CMS will follow-up to resolve issues, as necessary. Form Number: CMS–10464 (OCN: 0938–NEW); Frequency: Annually; Affected Public: Private Sector: Business or other for-profits; Number of Respondents: 254,095; Total Annual Responses: 254,095; Total Annual Hours: 1,206,951. (For policy questions regarding this collection contact Barry Brauth at 301–492–4299. For all other issues call 410–786–1326.) To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS’ Web site address at http://www.cms.hhs.gov/ PaperworkReductionActof1995, or Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call the Reports Clearance Office on (410) 786– 1326. In commenting on the proposed information collections please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in one of the following ways by April 8, 2013: 1. Electronically. You may submit your comments electronically to http:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: CMS–10464/OCN–0938– NEW, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244– 1850. Dated: February 3, 2013. Martique Jones, Deputy Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2013–02714 Filed 2–6–13; 8:45 am] BILLING CODE 4120–01–P E:\FR\FM\07FEN1.SGM 07FEN1

Agencies

[Federal Register Volume 78, Number 26 (Thursday, February 7, 2013)]
[Notices]
[Pages 9055-9056]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02792]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Health Statistics (NCHS), Classifications and 
Public Health Data Standards Staff, Announces the Following Meeting

Name: ICD-9-CM Coordination and Maintenance Committee (C&M) meeting.

Time and Date: 9:00 a.m.-5:00 p.m., March 5, 2013.

Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 
7500 Security Boulevard, Baltimore, Maryland 21244.

Status: Open to the public, limited only by the space available. The 
meeting room accommodates approximately 240 people. The meeting will be 
broadcast live via Webcast at http://www.cms.gov/live/

Security Considerations: Due to increased security requirements CMS has 
instituted stringent procedures for entrance into the building by non-
government employees. Attendees will need to present valid government-
issued picture identification, and sign-in at the security desk upon 
entering the building. Attendees who wish to attend a specific ICD-9-CM 
C&M meeting on March 5, 2013, must submit their name and organization 
by February 22, 2013, for inclusion on the visitor list. This visitor 
list will be maintained at the front desk of the CMS building and used 
by the guards to admit visitors to the meeting.
    Participants who attended previous ICD-9-CM C&M meetings will no 
longer be automatically added to the visitor list. You must request 
inclusion of your name prior to each meeting you attend.
    Please register to attend the meeting on-line at: http://www.cms.hhs.gov/apps/events/. Please contact Mady Hue (410-786-4510 or 
Marilu.hue@cms.hhs.gov), for questions about the registration process.

Purpose: The ICD-9-CM Coordination and Maintenance (C&M) Committee is a 
public forum for the presentation of proposed modifications to the 
International Classification of Diseases, Ninth Revision, Clinical 
Modification, the International Classification of Diseases, Tenth 
Revision, Clinical Modification and ICD-10--Procedure Coding System

Matters to be Discussed: Agenda items include:

[[Page 9056]]

March 5, 2013

ICD-9-CM Topics

Infusion of Prothrombin Complex Concentrate
Transprostatic Guided Implantable Struts

ICD-10 Topics

ICD-10 Implementation Announcements
ICD-10 Update on National Coverage Determinations
ICD-10 Impact Analysis
Transprostatic Guided Implantable Struts
ICD-10 HAC Translations
ICD-10-PCS Addendum

ICD-10-CM Diagnosis Topics

Complications of urinary devices (representation)
Gluten sensitivity
Salter Harris fractures
ICD-10-CM Addendum
    Agenda items are subject to change as priorities dictate.

    Note: CMS and NCHS will no longer provide paper copies of 
handouts for the meeting. Electronic copies of all meeting materials 
will be posted on the CMS and NCHS Web sites prior to the meeting at 
http://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and http://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.


Contact Persons for Additional Information: Donna Pickett, Medical 
Systems Administrator, Classifications and Public Health Data Standards 
Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, 
email dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue, 
Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security 
Boulevard, Baltimore, Maryland, 21244, email marilu.hue@cms.hhs.gov, 
telephone 410-786-4510 (procedures).
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2013-02792 Filed 2-6-13; 8:45 am]
BILLING CODE 4160-18-P